Chief Executive Officer Careers

The company is a global leader in the life sciences industry by providing essential services to ensure that health care products are developed, manufactured, and distributed to the highest standards, in compliance with all applicable regulatory requirements.

The firm is a publicly traded biopharmaceutical company dedicated to the development of novel therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders, including Alzheimer’s disease, Parkinson’s disease, Rett syndrome, schizophrenia and other central nervous system (CNS) diseases, pain, and various types of cancer.

The company is a pioneer in cancer care development that focuses on comprehensive genomic profiling (CGP) to match cancer patients with targeted therapies.

This company is on a mission to redefine fracture care by stripping away unnecessary complexity. They believe streamlined products are easier to manage, require less training, and lead to more efficient surgical procedures.

The corporate entity is a growth-stage medical device company with multiple FDA-cleared products, active commercial programs, and an advancing internal pipeline who is seeking a Chief Executive Officer to lead its next phase of scale and enterprise value creation.

The entity is a U.S. based, start-up biotechnology company focused on developing novel, natural prescription medicines derived from plants to treat mental health and central nervous system (CNS) disorders.

This company is a global innovator in the development of total artificial heart technology.

The firm is a privately held Delaware C corporation with a focus in the development and commercialization of innovative device-based clinical treatments for bloodstream infections.

The firm is a medical device company that develops extracorporeal blood filtration devices for removing harmful substances from the bloodstream of patients who are suffering from severe infections. Products are also being developed for the treatment of metastatic cancer.

The company is a global leader in the development, manufacture, and commercialization of innovative assays and instruments for the measurement of molecules in biological samples whose technology enhances medical research and drug development by enabling researchers to profile many biomarkers simultaneously in a single sample without compromising assay performance.

The organization is the Oregon’s trade association and champion for the life sciences industry. With members across biotech, medical devices, diagnostics, digital health, biomanufacturing, and supporting services, the firm works to advance discoveries, foster collaboration, strengthen the workforce, and grow Oregon’s innovation economy.

The company is a medtech venture developing the next generation of Left Atrial Appendage Occlusion (LAAO) technology to prevent stroke in patients with atrial fibrillation (AF).

The firm is an early-stage medical device company that develops non-invasive, low-power therapeutic ultrasound technology to treat open-angle glaucoma and ocular hypertension.

The company is a natural supplement company based in Las Vegas, Nevada with a mission to help men and women of all ages achieve their health and wellness goals with the most effective and healthy products on the market.

The organization is a fast-growing implantable medical devices company (Class III) based in Switzerland.

The corporate entity is a European medical technology company dedicated exclusively to developing and commercializing innovative solutions for Obstructive Sleep Apnea (OSA).

The organization is a clinical-stage European biopharmaceutical company that is a global leader in precision medicine and “precision prevention” for neurodegenerative diseases.

The company was formed in 2020 to commercialize patents from the Univ of Colorado for a non-invasive, wearable deep-tissue temperature sensor with applications in surgery, intensive care, military, athletics and consumer markets.

The firm is an emerging health technology company developing dosimetry-driven light therapy for the prevention and treatment of oral mucositis, a painful and debilitating complication of cancer therapy.

The organization is a leading provider of life sciences solutions worldwide by providing a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies.

The firm is a prominent medical device and rehabilitation technology company that designs, develops, and commercializes wearable bionic exoskeletons and physical therapy solutions.

The corporate organization is a pioneering biotechnology research and development company at the forefront of therapeutic innovation who is dedicated to discovering and developing novel treatments for complex diseases.

The corporation is Australia’s premier global life sciences and biotechnology giant, globally renowned for its leadership in blood plasma therapeutics.

The company is an Australian medical device innovator that designs and manufactures integrated, user-centric rapid diagnostic test (RDT) platforms.